Weili Wang

896 total citations
25 papers, 651 citations indexed

About

Weili Wang is a scholar working on Molecular Biology, Hematology and Cell Biology. According to data from OpenAlex, Weili Wang has authored 25 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Cell Biology. Recurrent topics in Weili Wang's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Acute Myeloid Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Weili Wang is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Acute Myeloid Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Weili Wang collaborates with scholars based in China, United States and Australia. Weili Wang's co-authors include Weiping Yuan, Tao Cheng, Zhuan Li, Bing Liu, Jie Zhou, Yanli Ni, Xiaohuan Mu, Wenyan He, Yu Lan and Fuchou Tang and has published in prestigious journals such as Nature, Blood and Nature Immunology.

In The Last Decade

Weili Wang

22 papers receiving 646 citations

Peers

Weili Wang

HEMAT

IMMUN

Deepak Kumar Jha United States

Samanta A. Mariani United States

Gwendolyn M. Mahon United States

Saiphone Webb United States

Sean F. Landrette United States

Paulina M. Strzelecka Germany

Tomoko Yamada-Inagawa Netherlands

Kathryn Austgen United States

Paul M. Sincock Australia

Thomas Cauvet Germany

Deepak Kumar Jha United States

Weili Wang

706 ×1.6

173 ×0.9

124 ×0.8

HEMAT

111 ×0.8

IMMUN

56 ×0.8

Citations per year, relative to Weili Wang Weili Wang (= 1×) peers Deepak Kumar Jha

Countries citing papers authored by Weili Wang

Since Specialization

Citations

This map shows the geographic impact of Weili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Wang more than expected).

Fields of papers citing papers by Weili Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Wang. The network helps show where Weili Wang may publish in the future.

Co-authorship network of co-authors of Weili Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Wang. A scholar is included among the top collaborators of Weili Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Wang. Weili Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Weili, Yizhen Chen, Liuting Wei, et al.. (2025). Single-cell transcriptomics combined with spatial transcriptomics reveals a fibrotic microenvironment in hyperuricemic nephropathy. European Journal of Pharmacology. 1005. 178062–178062.

Chen, Yizhen, Meng Cheng, Weili Wang, et al.. (2025). Identification of core noncoding RNA-associated competing endogenous RNA networks in renal fibrosis via whole-transcriptome sequencing. Renal Failure. 47(1). 2522973–2522973.

Chen, Yizhen, et al.. (2025). Mechanisms and therapeutic potential of multiple forms of programmed cell death in renal fibrosis. Cellular Signalling. 134. 111926–111926. 2 indexed citations

Cheng, Meng, Yizhen Chen, Weili Wang, et al.. (2025). Targeting Aquaporins for Renal Fibrosis Therapy: Mechanisms and Translational Potential. The FASEB Journal. 39(16). e70967–e70967.

Wang, Weili, Meng Cheng, Yizhen Chen, et al.. (2024). Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play?. Chinese Medicine. 19(1). 148–148. 5 indexed citations

Ren, Wei, Yuxin Zhang, Weili Wang, et al.. (2023). Structural and optical properties of Mn–Co–Ni–O and Mn–Zn–Ni–O medium-entropy oxide films. Journal of Materials Science Materials in Electronics. 34(5). 2 indexed citations

Yang, Xing, Chengrong Liu, Yafei Qu, et al.. (2022). KSHV-encoded ORF45 activates human NLRP1 inflammasome. Nature Immunology. 23(6). 916–926. 28 indexed citations

Gao, Juan, Yuxia Wang, Yanan Gao, et al.. (2021). Rheb1-Deficient Neutrophils Promote Hematopoietic Stem/Progenitor Cell Proliferation via Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology. 9. 650599–650599. 1 indexed citations

Wang, Weili, Tianyuan Hu, Le Wang, et al.. (2018). PDK1 regulates definitive HSCs via the FOXO pathway during murine fetal liver hematopoiesis. Stem Cell Research. 30. 192–200. 7 indexed citations

10.

Hu, Tianyuan, Cong Li, Le Wang, et al.. (2017). PDK1 plays a vital role on hematopoietic stem cell function. Scientific Reports. 7(1). 4943–4943. 11 indexed citations

11.

Li, Wenzheng, Weili Wang, Philip J. Uren, Luiz O. F. Penalva, & Andrew D. Smith. (2017). Riborex: fast and flexible identification of differential translation from Ribo-seq data. Bioinformatics. 33(11). 1735–1737. 61 indexed citations

12.

Zhou, Fan, Xianlong Li, Weili Wang, et al.. (2016). Tracing haematopoietic stem cell formation at single-cell resolution. Nature. 533(7604). 487–492. 263 indexed citations

13.

Gao, Yanan, Juan Gao, Minghao Li, et al.. (2016). Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia. Journal of Hematology & Oncology. 9(1). 36–36. 25 indexed citations

14.

Wang, Xiaomin, Yajing Chu, Weili Wang, & Weiping Yuan. (2016). mTORC signaling in hematopoiesis. International Journal of Hematology. 103(5). 510–518. 26 indexed citations

15.

Hu, Tianyuan, Cong Li, Yingchi Zhang, et al.. (2015). Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia. Biochemical and Biophysical Research Communications. 459(4). 692–698. 14 indexed citations

16.

Zhang, Yingchi, Tianyuan Hu, Chunlan Hua, et al.. (2014). Rictor Is Required for Early B Cell Development in Bone Marrow. PLoS ONE. 9(8). e103970–e103970. 27 indexed citations

17.

Lan, Yu, Wenyan He, Zhuan Li, et al.. (2014). Endothelial Smad4 restrains the transition to hematopoietic progenitors via suppression of ERK activation. Blood. 123(14). 2161–2171. 21 indexed citations

18.

Zhang, Yingchi, Chunlan Hua, Hui Cheng, et al.. (2013). Distinct sensitivity of CD8+CD4− and CD8+CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model. Leukemia Research. 37(11). 1592–1601. 8 indexed citations

19.

McLaughlin, William A., Tingjun Hou, Susan S. Taylor, & Weili Wang. (2010). The identification of novel cyclic AMP-dependent protein kinase anchoring proteins using bioinformatic filters and peptide arrays. Protein Engineering Design and Selection. 24(3). 333–339. 5 indexed citations

20.

Lin, Wey‐Jinq, et al.. (2001). Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Cα-binding protein rPICK1. Biochemical Journal. 354(3). 635–635. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact